These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 21572486

  • 1. [Pathophysiology of portal hypertension and mechanisms of sodium and water retention in cirrhosis].
    Garini G, Delsante M, Iannuzzella F.
    Recenti Prog Med; 2011 Mar; 102(3):134-40. PubMed ID: 21572486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M, Wexler MJ.
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A, Bolognesi M, Merkel C.
    Mol Aspects Med; 2008 Mar; 29(1-2):119-29. PubMed ID: 18036654
    [Abstract] [Full Text] [Related]

  • 5. [Edema in liver disease].
    Maekawa H, Toda G.
    Nihon Rinsho; 2005 Jan; 63(1):80-4. PubMed ID: 15675322
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of sodium retention and ascites formation in cirrhosis.
    Arroyo V, Ginès P.
    J Hepatol; 1993 Jan; 17 Suppl 2():S24-8. PubMed ID: 8491967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA, Harrison PM.
    Med Sci Monit; 2000 Jan; 6(4):807-16. PubMed ID: 11208415
    [Abstract] [Full Text] [Related]

  • 9. Ascites in liver diseases.
    Gentilini P, Laffi G.
    Ann Ital Med Int; 1991 Jan; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A, Bolognesi M, Sacerdoti D, Merkel C.
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathophysiology of portal hypertension.
    Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B.
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
    Martin PY, Ginès P, Schrier RW.
    N Engl J Med; 1998 Aug 20; 339(8):533-41. PubMed ID: 9709047
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.